Owen Bryan Holland, MD
NPI 1982622148ActiveIndividual· Internal Medicine, Endocrinology, Diabetes & Metabolism· Galveston, TX
Internal Medicine, Endocrinology, Diabetes & Metabolism (MD) in Galveston, Texas, licensed in TX, with an NPI issued in July 2006. Their prescriptions cost Medicare Part D more than their services did: $545,950 for 1,974 claims, against $11,985 paid for services in 2024. Novo Nordisk Inc was the largest of 6 companies reporting payments in 2025, $142.87 in all, mostly food and beverage.
Overview
| NPI | 1982622148 |
|---|---|
| Status | Active |
| Entity type | Individual |
| Credential | MD |
| Sole proprietor | No |
| NPI issued | Jul 17, 2006 |
| Last updated in NPPES | Feb 8, 2010 |
Specialties and licenses
| Taxonomy | Code | License | State |
|---|---|---|---|
| Internal Medicine, Endocrinology, Diabetes & Metabolism Primary | 207RE0101X | D5041 | TX |
| Internal Medicine | 207R00000X | D5041 | TX |
Exclusion screening
| List | Result | Details |
|---|---|---|
| HHS-OIG LEIE · Oct 9, 2026 | No match | Checked by NPI and by name + state |
| North Carolina Medicaid · Nov 4, 2026 | No match | — |
| New York OMIG · Nov 4, 2026 | No match | — |
| Ohio Medicaid · Nov 4, 2026 | No match | — |
| Pennsylvania Medicheck · Nov 4, 2026 | No match | — |
| Washington HCA · Nov 4, 2026 | No match | — |
Official OIG search · How matching works ·Bulk check a roster
Medicare
| Enrollment (PECOS) | Enrolled Practitioner - Endocrinology (TX) |
|---|---|
| Accepts assignment | Yes (participating) |
Medicare services in 2024
| Medicare patients | 55 |
|---|---|
| Services billed | 202 across 8 procedure codes |
| Paid by Medicare | $11,985 |
Part D prescriptions in 2024
| Prescriptions (claims) | 1,974 · 4,712 30-day fills |
|---|---|
| Patients | 146 |
| Total drug cost | $545,950 |
| Generic share | 64% of claims |
Industry payments (Open Payments)
- 2025$142.87 · 7 payments from 6 companies
- 2024$17.89 · 1 payment from 1 company
Top paying companies in 2025
| Company | Amount | Payments |
|---|---|---|
| Novo Nordisk Inc | $42.03 | 2 |
| Neurocrine Biosciences, Inc. | $26.63 | 1 |
| Dexcom, Inc. | $24.18 | 1 |
| Lilly USA, LLC | $18.29 | 1 |
| Corcept Therapeutics | $16.55 | 1 |
What the 2025 payments were for
- Food and Beverage$142.87 · 7 payments
Receiving payments does not imply wrongdoing. What Open Payments covers ·original records
Other Internal Medicine, Endocrinology, Diabetes & Metabolism providers in Galveston
- 1003377417
- 1780875963
- 1568521375
- 1487752804
- 1033278833
- 1255658340
- 1679197461
- 1487713996
- 1770642126
- 1073928016
- 1043877954
- 1053963389
All Internal Medicine, Endocrinology, Diabetes & Metabolism providers in Texas →